1352306-12-7 Usage
Description
1-(2,5-dihydroxyphenyl)-2-(3-hydroxyphenyl)ethanone, also known as rosmadial, is a polyphenolic flavonoid compound derived from certain plant species such as rosemary and Artemisia. It is recognized for its potent antioxidant properties and is being studied for its potential health benefits, which include protection against oxidative stress and inflammation. Rosmadial has also been investigated for its possible anti-cancer properties and is utilized in traditional medicine. Its promising biological activities suggest potential therapeutic applications in the pharmaceutical and cosmetic industries.
Uses
Used in Pharmaceutical Applications:
Rosmadial is used as a therapeutic agent for its antioxidant and anti-inflammatory properties, potentially offering protection against oxidative stress and inflammation-related conditions. Its exploration into anti-cancer properties makes it a candidate for further research and development in the pharmaceutical industry.
Used in Cosmetic Applications:
In the cosmetics industry, rosmadial is used as an active ingredient for its antioxidant properties, which can help protect the skin from environmental stressors and promote a healthier, more youthful appearance.
Used in Traditional Medicine:
Rosmadial has been a component of traditional medicine, where it is utilized for its general health-promoting and protective effects against various ailments, particularly those related to oxidative stress and inflammation.
Check Digit Verification of cas no
The CAS Registry Mumber 1352306-12-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,3,0 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1352306-12:
(9*1)+(8*3)+(7*5)+(6*2)+(5*3)+(4*0)+(3*6)+(2*1)+(1*2)=117
117 % 10 = 7
So 1352306-12-7 is a valid CAS Registry Number.
1352306-12-7Relevant articles and documents
Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927
Kahraman, Mehmet,Govek, Steven P.,Nagasawa, Johnny Y.,Lai, Andiliy,Bonnefous, Celine,Douglas, Karensa,Sensintaffar, John,Liu, Nhin,Lee, Kyoungjin,Aparicio, Anna,Kaufman, Josh,Qian, Jing,Shao, Gang,Prudente, Rene,Joseph, James D.,Darimont, Beatrice,Brigham, Daniel,Heyman, Richard,Rix, Peter J.,Hager, Jeffrey H.,Smith, Nicholas D.
, p. 50 - 55 (2019/01/15)
The further optimization of ER-α degradation efficacy of a series of ER modulators by refining side-chain substitution led to efficacious selective estrogen receptor degraders (SERDs). A fluoromethyl azetidine group was found to be preferred and resulted
HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
-
, (2016/12/22)
Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
ESTROGEN RECEPTOR MODULATOR AND USES THEREOF
-
, (2015/01/07)
Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in c
